Mount Sinai Health System Inc.

09/03/2024 | Press release | Distributed by Public on 09/03/2024 23:21

SGLT2 Inhibitor Empagliflozin Is Shown to Be Safe and Effective for Treating Patients Who Have Suffered a Heart Attack

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.